Hält derzeit Positionen bei Tricida Inc, ChemoCentryx Inc and Perrigo Company PLC
Position | Company | Period |
---|---|---|
Chief Financial Officer, Senior Vice President | Tricida Inc | 1. April 2017 - |
Independent Director | ChemoCentryx Inc | 1. Dezember 2009 - |
Independent Director | Perrigo Company PLC | 7. November 2016 - |
Independent Director | Genomic Health Inc | 21. Juni 2016 - 8. November 2019 |
Director | Sunesis Pharmaceuticals Inc | 23. März 2016 - 31. Dezember 2017 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-06 | 2024-01-30 |
Allogene Therapeutics Inc
(ALLO)
|
K Kauf |
190
+0.0%
3,60683 USD |
190 +0.0% | 3,60 | 683 USD | |
2023-07-31 | 2023-07-27 | K Kauf |
685.025
+199.7%
0,73500.000 USD |
685.025 +199.7% | 0,73 | 500.000 USD | ||
2023-06-14 | 2023-06-13 |
Perrigo Company PLC
(PRGO)
|
K Kauf |
10.000
+63.0%
33,06330.637 USD |
10.000 +63.0% | 33,06 | 330.637 USD | |
2023-04-12 | 2023-04-10 | K Kauf |
303.030
+757.6%
0,83250.000 USD |
303.030 +757.6% | 0,83 | 250.000 USD | ||
2023-03-07 | 2023-03-06 |
Perrigo Company PLC
(PRGO)
|
K Kauf |
5.000
+46.0%
38,05190.270 USD |
5.000 +46.0% | 38,05 | 190.270 USD | |
2021-12-17 | 2021-12-16 |
Perrigo Company PLC
(PRGO)
|
K Kauf |
5.000
+85.0%
36,85184.270 USD |
5.000 +85.0% | 36,85 | 184.270 USD | |
2021-12-16 | 2021-12-14 | K Kauf |
20.000
+60.0%
4,9498.800 USD |
20.000 +60.0% | 4,94 | 98.800 USD | ||
2021-03-18 | 2021-03-17 |
Perrigo Company PLC
(PRGO)
|
K Kauf |
2.500
+1666.7%
41,29103.218 USD |
2.500 +1666.7% | 41,29 | 103.218 USD | |
2021-03-08 | 2021-03-05 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
13.330
-51.2%
55,89744.974 USD |
13.330 -51.2% | 55,89 | 744.974 USD | |
2021-03-08 | 2021-03-05 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
16.670
-39.0%
56,78946.494 USD |
16.670 -39.0% | 56,78 | 946.494 USD | |
2021-03-08 | 2021-03-04 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
1.910
-4.3%
60,20114.980 USD |
1.910 -4.3% | 60,20 | 114.980 USD | |
2020-12-10 | 2020-12-10 |
Tricida Inc
(TCDA)
|
K Kauf |
15.000
+60.0%
6,78101.700 USD |
15.000 +60.0% | 6,78 | 101.700 USD | |
2020-05-12 | 2020-05-12 |
Tricida Inc
(TCDA)
|
K Kauf |
1.439
+1.5%
31,6645.559 USD |
1.439 +1.5% | 31,66 | 45.559 USD | |
2020-05-12 | 2020-05-12 |
Tricida Inc
(TCDA)
|
K Kauf |
1.303
+1.4%
30,0939.207 USD |
1.303 +1.4% | 30,09 | 39.207 USD | |
2020-05-12 | 2020-05-11 |
Tricida Inc
(TCDA)
|
K Kauf |
19.854
+27.4%
30,36602.767 USD |
19.854 +27.4% | 30,36 | 602.767 USD | |
2020-05-12 | 2020-05-11 |
Tricida Inc
(TCDA)
|
K Kauf |
12.404
+20.7%
29,48365.670 USD |
12.404 +20.7% | 29,48 | 365.670 USD | |
2020-03-25 | 2020-03-23 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
860
-1.7%
38,2132.863 USD |
860 -1.7% | 38,21 | 32.863 USD | |
2020-03-25 | 2020-03-23 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
13.959
-21.7%
37,40522.008 USD |
13.959 -21.7% | 37,40 | 522.008 USD | |
2020-03-25 | 2020-03-23 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
9.181
-12.5%
36,72337.100 USD |
9.181 -12.5% | 36,72 | 337.100 USD | |
2020-03-25 | 2020-03-23 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
2.801
-3.7%
35,3298.932 USD |
2.801 -3.7% | 35,32 | 98.932 USD | |
2020-03-25 | 2020-03-23 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
3.199
-4.0%
34,43110.147 USD |
3.199 -4.0% | 34,43 | 110.147 USD | |
2020-03-11 | 2020-03-10 |
Tricida Inc
(TCDA)
|
K Kauf |
5.000
+10.0%
29,46147.300 USD |
5.000 +10.0% | 29,46 | 147.300 USD | |
2019-06-03 | 2019-05-30 |
ChemoCentryx Inc
(CCXI)
|
V Verkauf |
12.815
-15.1%
12,00153.806 USD |
12.815 -15.1% | 12,00 | 153.806 USD |